| Field | Row 1 |
|---|---|
| adsh | 0001628280-25-030546 |
| cik | 1653482 |
| name | GITLAB INC. |
| sic | 7372 |
| countryba | US |
| stprba | CA |
| cityba | SAN FRANCISCO |
| zipba | 94104 |
| bas1 | 268 BUSH STREET |
| bas2 | #350 |
| baph | 650-474-5175 |
| countryma | US |
| stprma | CA |
| cityma | SAN FRANCISCO |
| zipma | 94104 |
| mas1 | 268 BUSH STREET |
| mas2 | #350 |
| countryinc | US |
| stprinc | DE |
| ein | 471861035 |
| former | |
| changed | |
| afs | 1-LAF |
| wksi | 0 |
| fye | 0131 |
| form | 10-Q |
| period | 20250430 |
| fy | 2026 |
| fp | Q1 |
| filed | 20250611 |
| accepted | 2025-06-10 17:38:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | gtlb-20250430_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-030546 | 20240430 | Stock Issued1 | 98000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 55827000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Assets | 1399263000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Assets | 46498000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Assets | 1441990000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Capital Expenditures Incurred But Not Yet Paid | 135000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Capitalized Contract Cost Amortization | 11109000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Capitalized Contract Cost Net Current | 38964000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Shares Issued | 144444000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Shares Outstanding | 144444000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250430 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20240430 | Comprehensive Income Net Of Tax | -53619000.0000 | USD | 1 | us-gaap/2025 | Restatement= Scenario Previously Reported; | ||
| 0001628280-25-030546 | 20250430 | Comprehensive Income Net Of Tax | -28826000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -357000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Contract With Customer Liability Noncurrent | 25981000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -42499000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Income Taxes Paid Net | 1011000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Other Noncurrent Liabilities | 12000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Intangible Assets Net Excluding Goodwill | 15819000.0000 | USD | 0 | us-gaap/2025 | (1) As of April 30, 2025 and January 31, 2025, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (JiHu), of $45.0 million and $46.5 million, respectively, and liabilities of $10.2 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to Note 10. Joint Venture for | ||
| 0001628280-25-030546 | 20250131 | Liabilities | 577957000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Net Cash Provided By Used In Operating Activities | 106302000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Operating Expenses | 224084000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Operating Lease Right Of Use Asset | 381000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Other Comprehensive Income Loss Net Of Tax | 6607000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Other Nonoperating Income Expense | -9971000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 5093000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Profit Loss | -243000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20240430 | Profit Loss | -54887000.0000 | USD | 1 | us-gaap/2025 | Restatement= Scenario Previously Reported; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 27652000.0000 | USD | 1 | us-gaap/2025 | Geographical= Europe; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 18008000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= License Professional Services And Other; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 5000000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Professional Services And Other; | ||
| 0001628280-25-030546 | 20250430 | Selling And Marketing Expense | 107587000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Selling And Marketing Expense | 1472000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Shares Outstanding | 145894000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stockholders Equity | 808280000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1167614000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001628280-25-030546 | 20250430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 852597000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Shares Restricted Stock Award Gross | 711000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Value Issued For Charitable Contributions | 1739000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Value Issued For Charitable Contributions | 1739000.0000 | USD | 1 | 0001628280-25-030546 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Accounts Payable Current | 11288000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Accounts Receivable Net Current | 264565000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Accretion Amortization Of Discounts And Premiums Investments | 2996000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Accrued Liabilities And Other Liabilities Current | 66308000.0000 | USD | 0 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250430 | Accumulated Other Comprehensive Income Loss Net Of Tax | -1459000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Additional Paid In Capital | 2013228000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 42252000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 42548000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20240430 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -296000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250430 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | -157000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250131 | Cash And Cash Equivalents At Carrying Value | 37991000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250131 | Contract With Customer Liability Current | 442599000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Contract With Customer Liability Noncurrent | 26369000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Cost Of Revenue | 19268000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription And Software; | ||
| 0001628280-25-030546 | 20250131 | Debt Securities Available For Sale Excluding Accrued Interest Current | 764728000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Donation Of Common Stock To Charitable Foundation | 2957000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20240430 | Earnings Per Share Basic | -0.3500 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Earnings Per Share Diluted | -0.2200 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Employee Related Liabilities Current | 28119000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Foreign Currency Transaction Gain Loss Unrealized | -720000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Foreign Currency Transaction Gain Loss Unrealized | -9901000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | General And Administrative Expense | 51087000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Income Tax Expense Benefit | 1000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Accrued Liabilities And Other Liabilities | 20023000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Other Noncurrent Assets | 419000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Liabilities | 10213000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Liabilities And Stockholders Equity | 1441990000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Liabilities Current | 556383000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Net Cash Provided By Used In Investing Activities | -81891000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Net Cash Provided By Used In Operating Activities | 38138000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Net Income Loss | -54644000.0000 | USD | 1 | us-gaap/2025 | Restatement= Scenario Previously Reported; | ||
| 0001628280-25-030546 | 20240430 | Net Income Loss Attributable To Noncontrolling Interest | -243000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Net Income Loss Attributable To Noncontrolling Interest | -243000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Operating Expenses | 204051000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Operating Income Loss | -1100000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250131 | Other Assets Noncurrent | 4437000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | -114000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 2807000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Loss Net Of Tax | 1200000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-030546 | 20240430 | Profit Loss | -55476000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Profit Loss | -35875000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 3171000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Professional Services And Other; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 20028000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= License Professional Services And Other; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 64185000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription Software As A Service; | ||
| 0001628280-25-030546 | 20250430 | Share Based Compensation | 55827000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Shares Outstanding | 19203000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 606392000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1768947000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 44317000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued1 | 38000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Shares Issued For Charitable Contributions | 53000.0000 | shares | 1 | 0001628280-25-030546 | Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Value Issued For Charitable Contributions | 2957000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Value Issued For Charitable Contributions | 2957000.0000 | USD | 1 | 0001628280-25-030546 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Accounts Receivable Net Current | 201408000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Amortization Of Intangible Assets | 2020000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Cash And Cash Equivalents At Carrying Value | 255719000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Cash And Cash Equivalents At Carrying Value | 97127000.0000 | USD | 0 | us-gaap/2025 | Balance Sheet Location= Cash And Cash Equivalents; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Money Market Funds; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20240430 | Cost Of Revenue | 13839000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription And Software; | ||
| 0001628280-25-030546 | 20250430 | Cost Of Revenue | 524000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Debt Securities Available For Sale Excluding Accrued Interest Current | 849113000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Earnings Per Share Diluted | -0.3500 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Goodwill | 16029000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Income Taxes Paid Net | -1295000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Income Tax Expense Benefit | 12710000.0000 | USD | 1 | us-gaap/2025 | Restatement= Scenario Previously Reported; | ||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Accounts Payable | 1336000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Accounts Receivable | -31072000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Accounts Receivable | -65928000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Contract With Customer Liability | -4448000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Minority Interest Period Increase Decrease | 410000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20240430 | Net Cash Provided By Used In Investing Activities | 89385000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Net Income Loss | -55233000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Operating Lease Right Of Use Asset | 329000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Operating Lease Right Of Use Asset | 329000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Other Assets Noncurrent | 4366000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | -442000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Other Comprehensive Income Loss Net Of Tax | 7049000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-030546 | 20250131 | Other Liabilities Noncurrent | 6557000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Nonoperating Income Expense | 347000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Other Nonoperating Income Expense | 26000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Prepaid Expense And Other Assets Current | 39066000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 3328000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Profit Loss | -589000.0000 | USD | 1 | us-gaap/2025 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 169187000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 1885000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 15028000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= License; | ||
| 0001628280-25-030546 | 20240430 | Selling And Marketing Expense | 1635000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 602402000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 46378000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 821306000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 45397000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Shares Conversion Of Convertible Securities | -622000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stock Repurchased During Period Shares | 1000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Weighted Average Number Of Diluted Shares Outstanding | 158157000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Weighted Average Number Of Shares Outstanding Basic | 158157000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Assets | 45029000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Capital Expenditures Incurred But Not Yet Paid | 119000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Cash And Cash Equivalents At Carrying Value | 227649000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Cash And Cash Equivalents At Carrying Value | 150611000.0000 | USD | 0 | us-gaap/2025 | Balance Sheet Location= Cash And Cash Equivalents; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
| 0001628280-25-030546 | 20250131 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 227649000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Shares Outstanding | 19469000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20240430 | General And Administrative Expense | 57487000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Goodwill | 16139000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Gross Profit | 1361000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Income Tax Expense Benefit | 267000.0000 | USD | 1 | us-gaap/2025 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Accrued Liabilities And Other Liabilities | 9979000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250430 | Investment Income Interest | 165000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 6197000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Nonoperating Income Expense | -322000.0000 | USD | 1 | us-gaap/2025 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-030546 | 20240430 | Payments To Acquire Available For Sale Securities Debt | 144392000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Proceeds From Sale Of Available For Sale Securities Debt | 1367000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Stockholders Equity | 775909000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -8508000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Shares Conversion Of Convertible Securities | 17236000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Shares Conversion Of Convertible Securities | 622000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250131 | Accounts Payable Current | 7519000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Accretion Amortization Of Discounts And Premiums Investments | 4900000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Accrued Liabilities And Other Liabilities Current | 54680000.0000 | USD | 0 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250131 | Accumulated Other Comprehensive Income Loss Net Of Tax | -8508000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Amortization Of Intangible Assets | 1087000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Cash And Cash Equivalents At Carrying Value | 133522000.0000 | USD | 0 | us-gaap/2025 | Balance Sheet Location= Cash And Cash Equivalents; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
| 0001628280-25-030546 | 20250430 | Cash And Cash Equivalents At Carrying Value | 7952000.0000 | USD | 0 | us-gaap/2025 | Balance Sheet Location= Cash And Cash Equivalents; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= Commercial Paper; | ||
| 0001628280-25-030546 | 20240131 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 287996000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 132326000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001628280-25-030546 | 20250430 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Shares Authorized | 1500000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250430 | Common Stock Shares Issued | 145894000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250430 | Common Stock Shares Issued | 19203000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250430 | Common Stock Shares Outstanding | 145894000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250430 | Common Stock Shares Outstanding | 19203000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250430 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20240430 | Comprehensive Income Net Of Tax | -414000.0000 | USD | 1 | us-gaap/2025 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-030546 | 20240430 | Cost Of Revenue | 18776000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Depreciation Depletion And Amortization | 556000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Donation Of Common Stock To Charitable Foundation | 1739000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20240430 | Gross Profit | 1162000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -33719000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Accounts Payable | 3586000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Capitalized Contract Costs | 8126000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Other Noncurrent Assets | -379000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Minority Interest Period Increase Decrease | -410000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Minority Interest Period Increase Decrease | 98000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Net Income Loss Attributable To Noncontrolling Interest | -383000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Operating Expenses | 2262000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 2632000.0000 | USD | 1 | us-gaap/2025 | Restatement= Scenario Previously Reported; | ||
| 0001628280-25-030546 | 20240430 | Payments To Acquire Businesses Net Of Cash Acquired | 20210000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Payments To Acquire Businesses Net Of Cash Acquired | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Profit Loss | -36258000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Research And Development Expense | 65410000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 1646000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 14837000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= License; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 33078000.0000 | USD | 1 | us-gaap/2025 | Geographical= Europe; | ||
| 0001628280-25-030546 | 20240430 | Share Based Compensation | 42252000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240131 | Shares Outstanding | 114670000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240131 | Shares Outstanding | 42887000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Shares Outstanding | 26212000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250131 | Shares Outstanding | 144444000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2398000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-030546 | 20250131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Shares Restricted Stock Award Gross | 787000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Shares Stock Options Exercised | 561000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Shares Stock Options Exercised | 357000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Value Stock Options Exercised | 3338000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Value Stock Options Exercised | 3338000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Weighted Average Number Of Shares Outstanding Basic | 164491000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Allowance For Doubtful Accounts Receivable Current | 991000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | A P I C Share Based Payment Arrangement Early Exercised Options Increase For Cost Recognition | 38000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250430 | A P I C Share Based Payment Arrangement Early Exercised Options Increase For Cost Recognition | 38000.0000 | USD | 1 | 0001628280-25-030546 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Assets Current | 1380761000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Capitalized Contract Cost Net Current | 35455000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Capitalized Contract Cost Net Noncurrent | 20142000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Cash And Cash Equivalents At Carrying Value | 36429000.0000 | USD | 0 | us-gaap/2025 | Balance Sheet Location= Cash And Cash Equivalents; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Treasury Securities; | ||
| 0001628280-25-030546 | 20240430 | Comprehensive Income Net Of Tax | -54033000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -29651000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Cost Of Revenue | 4937000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= License Professional Services And Other; | ||
| 0001628280-25-030546 | 20250430 | Cost Of Revenue | 25035000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 331000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Gross Profit | 189474000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Income Tax Expense Benefit | 2539000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Employee Related Liabilities | -13084000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Intangible Assets Net Excluding Goodwill | 17834000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Investment Income Interest | 10862000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Minority Interest | 44317000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Net Income Loss Attributable To Noncontrolling Interest | -383000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Operating Expenses | 2379000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Loss Net Of Tax | -114000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250430 | Other Comprehensive Income Loss Net Of Tax | -442000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250430 | Other Noncash Income Expense | -208000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Nonoperating Income Expense | -567000.0000 | USD | 1 | us-gaap/2025 | Restatement= Scenario Previously Reported; | ||
| 0001628280-25-030546 | 20240430 | Payments To Acquire Property Plant And Equipment | 700000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 254687000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Profit Loss | -828000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Profit Loss | -383000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250131 | Property Plant And Equipment Net | 322000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Property Plant And Equipment Net | 289000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 214509000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 4545000.0000 | USD | 1 | us-gaap/2025 | Geographical= Asia Pacific; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 176886000.0000 | USD | 1 | us-gaap/2025 | Geographical= U S; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 194481000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription And Software; | ||
| 0001628280-25-030546 | 20240131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1718661000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2013228000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Shares Issued For Charitable Contributions | 53226.0000 | shares | 1 | 0001628280-25-030546 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Shares Issued For Charitable Contributions | 40889.0000 | shares | 1 | 0001628280-25-030546 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Shares Issued For Charitable Contributions | 41000.0000 | shares | 1 | 0001628280-25-030546 | Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Value Issued For Charitable Contributions | 3000000.0000 | USD | 1 | 0001628280-25-030546 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20250430 | Weighted Average Number Of Diluted Shares Outstanding | 164491000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 55984000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20240430 | A P I C Share Based Payment Arrangement Early Exercised Options Increase For Cost Recognition | 98000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250430 | Cash And Cash Equivalents At Carrying Value | 37183000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 28070000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001628280-25-030546 | 20250131 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250131 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250430 | Common Stock Shares Authorized | 1500000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20240430 | Cost Of Revenue | 484000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20240430 | Depreciation Depletion And Amortization | 937000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -290000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Employee Related Liabilities Current | 40233000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Gross Profit | 150411000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -322000.0000 | USD | 1 | us-gaap/2025 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-030546 | 20240430 | Income Tax Expense Benefit | 12977000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Employee Related Liabilities | -13152000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Other Noncurrent Liabilities | 2806000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -10362000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Investment Income Interest | 12030000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Investment Income Interest | 227000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250430 | Liabilities | 589393000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Minority Interest | 45397000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Net Cash Provided By Used In Financing Activities | 5093000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -1721000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Nonoperating Income Expense | -889000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Profit Loss | -55233000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001628280-25-030546 | 20250131 | Retained Earnings Accumulated Deficit | -1167614000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 103673000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription And Circulation; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 47506000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription Software As A Service; | ||
| 0001628280-25-030546 | 20250430 | Revenue From Contract With Customer Excluding Assessed Tax | 130296000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription And Circulation; | ||
| 0001628280-25-030546 | 20240430 | Selling And Marketing Expense | 92424000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Shares Outstanding | 132670000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3598000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-030546 | 20250131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Value Issued For Charitable Contributions | 1700000.0000 | USD | 1 | 0001628280-25-030546 | Class Of Stock= Common Class A; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Value Stock Options Exercised | 5093000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Value Stock Options Exercised | 5093000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250131 | Additional Paid In Capital | 1952031000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Allowance For Doubtful Accounts Receivable Current | 1154000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | A P I C Share Based Payment Arrangement Early Exercised Options Increase For Cost Recognition | 98000.0000 | USD | 1 | 0001628280-25-030546 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250131 | Assets Current | 1336317000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Capitalized Contract Cost Amortization | 13899000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Capitalized Contract Cost Net Noncurrent | 19830000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Cash And Cash Equivalents At Carrying Value | 97093000.0000 | USD | 0 | us-gaap/2025 | Balance Sheet Location= Cash And Cash Equivalents; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Financial Instrument= Money Market Funds; | ||
| 0001628280-25-030546 | 20250430 | Cash And Cash Equivalents At Carrying Value | 45532000.0000 | USD | 0 | us-gaap/2025 | Balance Sheet Location= Cash And Cash Equivalents; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Financial Instrument= U S Treasury Securities; | ||
| 0001628280-25-030546 | 20240430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 420322000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 255719000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Common Stock Shares Issued | 19469000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
| 0001628280-25-030546 | 20250430 | Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -825000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -54390000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Contract With Customer Liability Current | 450668000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Cost Of Revenue | 5767000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= License Professional Services And Other; | ||
| 0001628280-25-030546 | 20250430 | Earnings Per Share Basic | -0.2200 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -42177000.0000 | USD | 1 | us-gaap/2025 | Restatement= Scenario Previously Reported; | ||
| 0001628280-25-030546 | 20240430 | Increase Decrease In Capitalized Contract Costs | 8540000.0000 | USD | 1 | 0001628280-25-030546 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Contract With Customer Liability | 1205000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -1527000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Liabilities | 10278000.0000 | USD | 0 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250131 | Liabilities And Stockholders Equity | 1399263000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Liabilities Current | 545031000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Minority Interest Period Increase Decrease | -98000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20250430 | Net Cash Provided By Used In Financing Activities | 3328000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Net Income Loss | -589000.0000 | USD | 1 | us-gaap/2025 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-030546 | 20250430 | Net Income Loss | -35875000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Operating Income Loss | -53640000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Operating Income Loss | -34610000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Operating Income Loss | -1018000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250131 | Operating Lease Right Of Use Asset | 381000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | 175000.0000 | USD | 1 | us-gaap/2025 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-030546 | 20250430 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | 410000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Comprehensive Income Loss Net Of Tax | 1086000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Other Liabilities Noncurrent | 7029000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Other Noncash Income Expense | -412000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Payments To Acquire Available For Sale Securities Debt | 245952000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Payments To Acquire Property Plant And Equipment | 912000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250131 | Prepaid Expense And Other Assets Current | 40411000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 163606000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Proceeds From Sale Of Available For Sale Securities Debt | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Profit Loss | -526000.0000 | USD | 1 | us-gaap/2025 | Consolidated Entities= Variable Interest Entity Primary Beneficiary; | ||
| 0001628280-25-030546 | 20250131 | Property Plant And Equipment Net | 4013000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Property Plant And Equipment Net | 4856000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Research And Development Expense | 54140000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20250430 | Retained Earnings Accumulated Deficit | -1203489000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 4009000.0000 | USD | 1 | us-gaap/2025 | Geographical= Asia Pacific; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 137526000.0000 | USD | 1 | us-gaap/2025 | Geographical= U S; | ||
| 0001628280-25-030546 | 20240430 | Revenue From Contract With Customer Excluding Assessed Tax | 151179000.0000 | USD | 1 | us-gaap/2025 | Product Or Service= Subscription And Software; | ||
| 0001628280-25-030546 | 20250131 | Shares Outstanding | 19469000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 46621000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
| 0001628280-25-030546 | 20240131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1161288000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001628280-25-030546 | 20240430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20240430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1216521000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001628280-25-030546 | 20250131 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1952031000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-030546 | 20250430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1459000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-030546 | 20250430 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1203489000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001628280-25-030546 | 20240430 | Stock Issued During Period Shares Conversion Of Convertible Securities | -17236000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; | ||
| 0001628280-25-030546 | 20250430 | Stock Issued During Period Shares Stock Options Exercised | 357000.0000 | shares | 1 | us-gaap/2025 | Class Of Stock= Common Class B; Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Stock Issued1 | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued | The fair value of stock issued in noncash financing activities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2025 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of unrealized gain (loss) from foreign currency transaction. |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Employee Related Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Investment Income Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Increase Decrease In Capitalized Contract Costs | 0001628280-25-030546 | 1 | 0 | monetary | D | C | Increase (Decrease) In Capitalized Contract Costs | Increase (Decrease) In Capitalized Contract Costs |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Profit Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Minority Interest | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
| Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Amortization Of Intangible Assets | us-gaap/2025 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. |
| Capitalized Contract Cost Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Capitalized Contract Cost, Amortization | Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2025 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | D | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests. |
| Payments To Acquire Businesses Net Of Cash Acquired | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Businesses, Net of Cash Acquired | The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale | Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Accrued Liabilities And Other Liabilities Current | 0001628280-25-030546 | 1 | 0 | monetary | I | C | Accrued Liabilities and Other Liabilities, Current | Accrued Liabilities and Other Liabilities, Current |
| Stock Issued During Period Value Issued For Charitable Contributions | 0001628280-25-030546 | 1 | 0 | monetary | D | C | Stock Issued During Period, Value, Issued for Charitable Contributions | Stock Issued During Period, Value, Issued for Charitable Contributions |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Capitalized Contract Cost Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Capitalized Contract Cost, Net, Current | Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current. |
| Capitalized Contract Cost Net Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Capitalized Contract Cost, Net, Noncurrent | Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent. |
| Contract With Customer Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Noncurrent | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent. |
| Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Payments To Acquire Available For Sale Securities Debt | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Debt Securities, Available-for-Sale | Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Selling And Marketing Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Contract With Customer Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
| Increase Decrease In Employee Related Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. |
| Other Noncash Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| A P I C Share Based Payment Arrangement Early Exercised Options Increase For Cost Recognition | 0001628280-25-030546 | 1 | 0 | monetary | D | C | APIC, Share-based Payment Arrangement, Early Exercised Options, Increase for Cost Recognition | APIC, Share-based Payment Arrangement, Early Exercised Options, Increase for Cost Recognition |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Debt Securities Available For Sale Excluding Accrued Interest Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current | Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current. |
| Goodwill | us-gaap/2025 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
| Other Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Stock Repurchased During Period Shares | us-gaap/2025 | 0 | 0 | shares | D | Stock Repurchased During Period, Shares | Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. | |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2025 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
| Proceeds From Sale Of Available For Sale Securities Debt | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Sale of Debt Securities, Available-for-Sale | Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Donation Of Common Stock To Charitable Foundation | 0001628280-25-030546 | 1 | 0 | monetary | D | D | Donation of Common Stock to Charitable Foundation | Donation of Common Stock to Charitable Foundation |
| Increase Decrease In Accrued Liabilities And Other Liabilities | 0001628280-25-030546 | 1 | 0 | monetary | D | D | Increase (Decrease) In Accrued Liabilities And Other Liabilities | Increase (Decrease) In Accrued Liabilities And Other Liabilities |
| Stock Issued During Period Shares Issued For Charitable Contributions | 0001628280-25-030546 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Issued for Charitable Contributions | Stock Issued During Period, Shares, Issued for Charitable Contributions | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | D | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Increase Decrease In Other Noncurrent Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. |
| Minority Interest Period Increase Decrease | us-gaap/2025 | 0 | 0 | monetary | D | Noncontrolling Interest, Period Increase (Decrease) | Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period. | |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Income Taxes Paid Net | us-gaap/2025 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2025 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Allowance For Doubtful Accounts Receivable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Receivable, Allowance for Credit Loss, Current | Amount of allowance for credit loss on accounts receivable, classified as current. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-030546 | 2 | 9 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001628280-25-030546 | 2 | 10 | BS | 0 | H | Debt Securities Available For Sale Excluding Accrued Interest Current | us-gaap/2025 | Short-term investments | 0 |
| 0001628280-25-030546 | 2 | 11 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable, net of allowance for doubtful accounts of $1,154 and $991 as of April 30, 2025 and January 31, 2025, respectively | 0 |
| 0001628280-25-030546 | 2 | 12 | BS | 0 | H | Capitalized Contract Cost Net Current | us-gaap/2025 | Deferred contract acquisition costs, current | 0 |
| 0001628280-25-030546 | 2 | 13 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001628280-25-030546 | 2 | 14 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001628280-25-030546 | 2 | 15 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
| 0001628280-25-030546 | 2 | 16 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease right-of-use assets | 0 |
| 0001628280-25-030546 | 2 | 17 | BS | 0 | H | Goodwill | us-gaap/2025 | Goodwill | 0 |
| 0001628280-25-030546 | 2 | 18 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2025 | Intangible assets, net | 0 |
| 0001628280-25-030546 | 2 | 19 | BS | 0 | H | Capitalized Contract Cost Net Noncurrent | us-gaap/2025 | Deferred contract acquisition costs, non-current | 0 |
| 0001628280-25-030546 | 2 | 20 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other non-current assets | 0 |
| 0001628280-25-030546 | 2 | 21 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001628280-25-030546 | 2 | 24 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001628280-25-030546 | 2 | 25 | BS | 0 | H | Accrued Liabilities And Other Liabilities Current | 0001628280-25-030546 | Accrued expenses and other current liabilities | 0 |
| 0001628280-25-030546 | 2 | 26 | BS | 0 | H | Employee Related Liabilities Current | us-gaap/2025 | Accrued compensation and benefits | 0 |
| 0001628280-25-030546 | 2 | 27 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2025 | Deferred revenue, current | 0 |
| 0001628280-25-030546 | 2 | 28 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001628280-25-030546 | 2 | 29 | BS | 0 | H | Contract With Customer Liability Noncurrent | us-gaap/2025 | Deferred revenue, non-current | 0 |
| 0001628280-25-030546 | 2 | 30 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2025 | Other non-current liabilities | 0 |
| 0001628280-25-030546 | 2 | 31 | BS | 0 | H | Liabilities | us-gaap/2025 | TOTAL LIABILITIES | 0 |
| 0001628280-25-030546 | 2 | 32 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and contingencies (Note 13) | 0 |
| 0001628280-25-030546 | 2 | 34 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred stock, $0.0000025 par value; 50,000 shares authorized as of April 30, 2025 and January 31, 2025; no shares issued and outstanding as of April 30, 2025 and January 31, 2025 | 0 |
| 0001628280-25-030546 | 2 | 35 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, value, issued | 0 |
| 0001628280-25-030546 | 2 | 36 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001628280-25-030546 | 2 | 37 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001628280-25-030546 | 2 | 38 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Accumulated other comprehensive loss | 0 |
| 0001628280-25-030546 | 2 | 39 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total GitLab stockholders equity | 0 |
| 0001628280-25-030546 | 2 | 40 | BS | 0 | H | Minority Interest | us-gaap/2025 | Noncontrolling interests | 0 |
| 0001628280-25-030546 | 2 | 41 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | TOTAL STOCKHOLDERS EQUITY | 0 |
| 0001628280-25-030546 | 2 | 42 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 0 |
| 0001628280-25-030546 | 3 | 10 | BS | 1 | H | Allowance For Doubtful Accounts Receivable Current | us-gaap/2025 | Allowance for doubtful accounts | 0 |
| 0001628280-25-030546 | 3 | 12 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock, par value (in USD per share) | 0 |
| 0001628280-25-030546 | 3 | 13 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, shares authorized (in shares) | 0 |
| 0001628280-25-030546 | 3 | 14 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, shares issued (in shares) | 0 |
| 0001628280-25-030546 | 3 | 15 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001628280-25-030546 | 3 | 16 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in USD per share) | 0 |
| 0001628280-25-030546 | 3 | 17 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized (in shares) | 0 |
| 0001628280-25-030546 | 3 | 18 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued (in shares) | 0 |
| 0001628280-25-030546 | 3 | 19 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding (in shares) | 0 |
| 0001628280-25-030546 | 3 | 20 | BS | 1 | H | Assets | us-gaap/2025 | Assets of consolidated variable interest entity | 0 |
| 0001628280-25-030546 | 3 | 21 | BS | 1 | H | Liabilities | us-gaap/2025 | Liabilities of consolidated variable interest entity | 0 |
| 0001628280-25-030546 | 4 | 7 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | Revenue | 0 |
| 0001628280-25-030546 | 4 | 8 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of revenue | 0 |
| 0001628280-25-030546 | 4 | 9 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross profit | 0 |
| 0001628280-25-030546 | 4 | 11 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2025 | Sales and marketing | 0 |
| 0001628280-25-030546 | 4 | 12 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
| 0001628280-25-030546 | 4 | 13 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001628280-25-030546 | 4 | 14 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001628280-25-030546 | 4 | 15 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
| 0001628280-25-030546 | 4 | 16 | IS | 0 | H | Investment Income Interest | us-gaap/2025 | Interest income | 0 |
| 0001628280-25-030546 | 4 | 17 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2025 | Other expense, net | 0 |
| 0001628280-25-030546 | 4 | 18 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Loss before income taxes | 0 |
| 0001628280-25-030546 | 4 | 19 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income taxes | 0 |
| 0001628280-25-030546 | 4 | 20 | IS | 0 | H | Profit Loss | us-gaap/2025 | Net loss | 0 |
| 0001628280-25-030546 | 4 | 21 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2025 | Net loss attributable to noncontrolling interest | 0 |
| 0001628280-25-030546 | 4 | 22 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss attributable to GitLab | 0 |
| 0001628280-25-030546 | 4 | 23 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in dollars per share) | 0 |
| 0001628280-25-030546 | 4 | 24 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in dollars per share) | 0 |
| 0001628280-25-030546 | 4 | 25 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic (in shares) | 0 |
| 0001628280-25-030546 | 4 | 26 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares) | 0 |
| 0001628280-25-030546 | 5 | 1 | CI | 0 | H | Profit Loss | us-gaap/2025 | Net loss | 0 |
| 0001628280-25-030546 | 5 | 2 | CI | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2025 | Foreign currency translation adjustments | 0 |
| 0001628280-25-030546 | 5 | 3 | CI | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2025 | Net change in unrealized gains (losses) on available-for-sale securities | 0 |
| 0001628280-25-030546 | 5 | 4 | CI | 0 | H | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Comprehensive loss including noncontrolling interest | 0 |
| 0001628280-25-030546 | 5 | 5 | CI | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2025 | Net loss attributable to noncontrolling interest | 0 |
| 0001628280-25-030546 | 5 | 6 | CI | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Foreign currency translation adjustments attributable to noncontrolling interest | 0 |
| 0001628280-25-030546 | 5 | 7 | CI | 0 | H | Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | us-gaap/2025 | Comprehensive loss attributable to noncontrolling interest | 0 |
| 0001628280-25-030546 | 5 | 8 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive loss attributable to GitLab | 0 |
| 0001628280-25-030546 | 6 | 15 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Stockholders' Equity, beginning balance (in shares) | 0 |
| 0001628280-25-030546 | 6 | 16 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Stockholders' Equity, beginning balance | 0 |
| 0001628280-25-030546 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2025 | Conversion of stock (in shares) | 0 |
| 0001628280-25-030546 | 6 | 18 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | Issuance of common stock related to vested exercised stock options (in shares) | 0 |
| 0001628280-25-030546 | 6 | 19 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | Issuance of common stock related to vested exercised stock options | 0 |
| 0001628280-25-030546 | 6 | 20 | EQ | 0 | H | Stock Repurchased During Period Shares | us-gaap/2025 | Repurchases, net of early exercised stock options (in shares) | 1 |
| 0001628280-25-030546 | 6 | 21 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2025 | Issuance of common stock related to RSUs vested (in shares) | 0 |
| 0001628280-25-030546 | 6 | 22 | EQ | 0 | H | Stock Issued During Period Shares Issued For Charitable Contributions | 0001628280-25-030546 | Charitable donation of common stock (in shares) | 0 |
| 0001628280-25-030546 | 6 | 23 | EQ | 0 | H | Stock Issued During Period Value Issued For Charitable Contributions | 0001628280-25-030546 | Charitable donation of common stock | 0 |
| 0001628280-25-030546 | 6 | 24 | EQ | 0 | H | A P I C Share Based Payment Arrangement Early Exercised Options Increase For Cost Recognition | 0001628280-25-030546 | Vesting of early exercised stock options | 0 |
| 0001628280-25-030546 | 6 | 25 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001628280-25-030546 | 6 | 26 | EQ | 0 | H | Minority Interest Period Increase Decrease | us-gaap/2025 | Other comprehensive loss | 0 |
| 0001628280-25-030546 | 6 | 27 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Other comprehensive loss | 0 |
| 0001628280-25-030546 | 6 | 28 | EQ | 0 | H | Profit Loss | us-gaap/2025 | Net loss | 0 |
| 0001628280-25-030546 | 6 | 29 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Stockholders' Equity, ending balance (in shares) | 0 |
| 0001628280-25-030546 | 6 | 30 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Stockholders' Equity, ending balance | 0 |
| 0001628280-25-030546 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2025 | Net loss, including amounts attributable to noncontrolling interest | 0 |
| 0001628280-25-030546 | 7 | 4 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001628280-25-030546 | 7 | 5 | CF | 0 | H | Donation Of Common Stock To Charitable Foundation | 0001628280-25-030546 | Charitable donation of common stock | 0 |
| 0001628280-25-030546 | 7 | 6 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2025 | Amortization of intangible assets | 0 |
| 0001628280-25-030546 | 7 | 7 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2025 | Depreciation expense | 0 |
| 0001628280-25-030546 | 7 | 8 | CF | 0 | H | Capitalized Contract Cost Amortization | us-gaap/2025 | Amortization of deferred contract acquisition costs | 0 |
| 0001628280-25-030546 | 7 | 9 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2025 | Net amortization of premiums or discounts on short-term investments | 1 |
| 0001628280-25-030546 | 7 | 10 | CF | 0 | H | Foreign Currency Transaction Gain Loss Unrealized | us-gaap/2025 | Unrealized foreign exchange loss, net | 1 |
| 0001628280-25-030546 | 7 | 11 | CF | 0 | H | Other Noncash Income Expense | us-gaap/2025 | Other non-cash expense, net | 1 |
| 0001628280-25-030546 | 7 | 13 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable | 1 |
| 0001628280-25-030546 | 7 | 14 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other current assets | 1 |
| 0001628280-25-030546 | 7 | 15 | CF | 0 | H | Increase Decrease In Capitalized Contract Costs | 0001628280-25-030546 | Deferred contract acquisition costs | 1 |
| 0001628280-25-030546 | 7 | 16 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | Other non-current assets | 1 |
| 0001628280-25-030546 | 7 | 17 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001628280-25-030546 | 7 | 18 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Liabilities | 0001628280-25-030546 | Accrued expenses and other current liabilities | 0 |
| 0001628280-25-030546 | 7 | 19 | CF | 0 | H | Increase Decrease In Employee Related Liabilities | us-gaap/2025 | Accrued compensation and benefits | 0 |
| 0001628280-25-030546 | 7 | 20 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2025 | Deferred revenue | 0 |
| 0001628280-25-030546 | 7 | 21 | CF | 0 | H | Increase Decrease In Other Noncurrent Liabilities | us-gaap/2025 | Other non-current liabilities | 0 |
| 0001628280-25-030546 | 7 | 22 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash provided by operating activities | 0 |
| 0001628280-25-030546 | 7 | 24 | CF | 0 | H | Payments To Acquire Available For Sale Securities Debt | us-gaap/2025 | Purchases of short-term investments | 1 |
| 0001628280-25-030546 | 7 | 25 | CF | 0 | H | Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | us-gaap/2025 | Proceeds from maturities of short-term investments | 0 |
| 0001628280-25-030546 | 7 | 26 | CF | 0 | H | Proceeds From Sale Of Available For Sale Securities Debt | us-gaap/2025 | Proceeds from sales of short-term investments | 0 |
| 0001628280-25-030546 | 7 | 27 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchases of property and equipment | 1 |
| 0001628280-25-030546 | 7 | 28 | CF | 0 | H | Payments To Acquire Businesses Net Of Cash Acquired | us-gaap/2025 | Payments for business combination, net of cash acquired | 1 |
| 0001628280-25-030546 | 7 | 29 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash provided by (used in) investing activities | 0 |
| 0001628280-25-030546 | 7 | 31 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2025 | Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases | 0 |
| 0001628280-25-030546 | 7 | 32 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001628280-25-030546 | 7 | 33 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Impact of foreign exchange on cash and cash equivalents | 0 |
| 0001628280-25-030546 | 7 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net increase in cash and cash equivalents | 0 |
| 0001628280-25-030546 | 7 | 35 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and cash equivalents at beginning of period | 0 |
| 0001628280-25-030546 | 7 | 36 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash and cash equivalents at end of period | 0 |
| 0001628280-25-030546 | 7 | 38 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2025 | Cash paid (refunds) for income taxes | 0 |
| 0001628280-25-030546 | 7 | 40 | CF | 0 | H | Stock Issued1 | us-gaap/2025 | Vesting of early exercised stock options | 0 |
| 0001628280-25-030546 | 7 | 41 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2025 | Unpaid property and equipment in accounts payable | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |